Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;16(8):990-994.
doi: 10.1177/1747493020984073. Epub 2021 Jan 14.

Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial

Melinda B Roaldsen  1   2 , Haakon Lindekleiv  3 , Agnethe Eltoft  1   2 , Mirza Jusufovic  4 , Mary-Helen Søyland  5 , Jesper Petersson  6 , Bent Indredavik  7 , Arnstein Tveiten  5 , Jukka Putaala  8 , Hanne Christensen  9 , Janika Kõrv  10 , Dalius Jatužis  11 , Stefan T Engelter  12   13 , Gian Marco De Marchis  12 , Tom Wilsgaard  14 , David J Werring  15 , Thompson Robinson  16 , Ellisiv B Mathiesen  1   2 , Eivind Berge  2   17
Affiliations

Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial

Melinda B Roaldsen et al. Int J Stroke. 2021 Oct.

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] Int J Stroke. 2021 Dec;16(9):NP1. doi: 10.1177/1747493021995410. Epub 2021 Feb 10. Int J Stroke. 2021. PMID: 33565945 Free PMC article. No abstract available.

Abstract

Background: Patients with wake-up ischemic stroke who have evidence of salvageable tissue on advanced imaging can benefit from intravenous thrombolysis. It is not known whether patients who do not fulfil such imaging criteria might benefit from treatment, but studies indicate that treatment based on non-contrast CT criteria may be safe. Tenecteplase has shown promising results in patients with acute ischemic stroke. The aim of the Tenecteplase in Wake-up Ischemic Stroke Trial (TWIST) is to compare the effect of thrombolytic treatment with tenecteplase and standard care versus standard care alone in patients with wake-up ischemic stroke selected by non-contrast CT.

Methods/design: TWIST is an international, investigator-initiated, multi-centre, prospective, randomized-controlled, open-label, blinded end-point trial of tenecteplase (n = 300) versus standard care (n = 300) in patients who wake up with an acute ischemic stroke and can be treated within 4.5 h upon awakening. Seventy-seven centres in 10 countries (Denmark, Estonia, Finland, Latvia, Lithuania, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom) participate. The primary outcome is the modified Rankin Scale on the ordinal scale (0-6) at three months.

Discussion: TWIST aims to determine the effect and safety of thrombolytic treatment with tenecteplase in patients with wake-up ischemic stroke selected by non-contrast CT.

Trial registration: ClinicalTrials.gov NCT03181360. EudraCT Number 2014-000096-80.

Keywords: TWIST; Tenecteplase; acute ischemic stroke; intravenous thrombolysis; wake-up stroke.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The cost of tenecteplase is covered by an unconditional grant from Boehringer Ingelheim Norway KS.

Ingelheim and Bayer, and grants from Daiichy-Sankyo.

References

    1. IST-3; collaborative group Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352–2363. - PMC - PubMed
    1. Bassetti C, Aldrich M. Night time versus daytime transient ischaemic attack and ischaemic stroke: a prospective study of 110 patients. J Neurol Neurosurg Psychiatry 1999; 67: 463–467. - PMC - PubMed
    1. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018; 379: 611–622. - PubMed
    1. Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Eng J Med 2019; 380: 1795–1803. - PubMed
    1. Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011; 10: 978–986. - PubMed

Publication types

MeSH terms

Associated data